Reneo Pharmaceuticals, Inc. (RPHM) Financials
Stock symbol RPHM is outdated, potentially delisted? Maybe it is available on other exchange?
RPHM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 130.4 million | 15.4 million |
| June 30, 2023 | 148.0 million | 15.5 million |
| March 31, 2023 | 98.9 million | 11.8 million |
| Dec. 31, 2022 | 108.2 million | 8.2 million |
RPHM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -18.8 million | 1.4 million |
| June 30, 2023 | -16.1 million | 1.2 million |
| March 31, 2023 | -9.2 million | 1.2 million |
| Dec. 31, 2022 | -15.9 million | 1.2 million |
RPHM Net Income
No data available :(
RPHM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 125.6 million | - | 1.1 million |
| June 30, 2023 | 142.7 million | - | 1.2 million |
| March 31, 2023 | 93.8 million | - | 1.3 million |
| Dec. 31, 2022 | 101.2 million | - | 1.5 million |
RPHM Shares Outstanding
RPHM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 19000 | 13.6 million | 7.3 million | - |
| June 30, 2023 | 5000 | 14.4 million | 6.6 million | - |
| March 31, 2023 | 172000 | 11.0 million | 5.1 million | - |
| Dec. 31, 2022 | 250000 | 10.4 million | 4.2 million | - |
RPHM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 43000 |
| June 30, 2023 | - | 163000 |
| March 31, 2023 | - | 161000 |
| Dec. 31, 2022 | - | 128000 |
RPHM
Price: $18.20
52 week price:
Earnings Per Share: -1.68 USD
P/E Ratio: -0.74
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 37300
Market Capitalization: 43.8 million